201 related articles for article (PubMed ID: 37782096)
1. Analysis of death cases in Shenyang City, China, for immunization adverse event surveillance, 2009-2021.
Gao D; Dong G; Zhu L; Jia N; Sun B
Hum Vaccin Immunother; 2023 Aug; 19(2):2263225. PubMed ID: 37782096
[TBL] [Abstract][Full Text] [Related]
2. Deaths reported to national surveillance for adverse events following immunization in China, 2010-2015.
Wu W; Liu D; Nuorti JP; Li K; Xu D; Ye J; Zheng J; Cao L; Wang H
Vaccine; 2019 Feb; 37(9):1182-1187. PubMed ID: 30709723
[TBL] [Abstract][Full Text] [Related]
3. [Analysis on the characteristics of suspected vaccine-related deaths in Fujian Province, 2012-2017].
Xiao JX; Lin ZQ; Wu RH; Zhou Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jul; 53(7):719-723. PubMed ID: 31288344
[No Abstract] [Full Text] [Related]
4. Surveillance of adverse events following immunization in China: Past, present, and future.
Liu D; Wu W; Li K; Xu D; Ye J; Li L; Wang H
Vaccine; 2015 Jul; 33(32):4041-6. PubMed ID: 25936727
[TBL] [Abstract][Full Text] [Related]
5. Analysis of adverse events following immunization in Zhejiang, China, 2019: a retrospective cross-sectional study based on the passive surveillance system.
Pan X; Lv H; Chen F; Wang Y; Liang H; Shen L; Chen Y; Hu Y
Hum Vaccin Immunother; 2021 Oct; 17(10):3823-3830. PubMed ID: 34170800
[No Abstract] [Full Text] [Related]
6. The characteristics and trend of adverse events following immunization reported by information system in Jiangsu province, China, 2015-2018.
Hu R; Peng S; Liu Y; Tang F; Wang Z; Zhang L; Gao J; Guo H
BMC Public Health; 2021 Jul; 21(1):1338. PubMed ID: 34229643
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of 'SAEFVIC', A Pharmacovigilance Surveillance Scheme for the Spontaneous Reporting of Adverse Events Following Immunisation in Victoria, Australia.
Clothier HJ; Crawford NW; Russell M; Kelly H; Buttery JP
Drug Saf; 2017 Jun; 40(6):483-495. PubMed ID: 28342074
[TBL] [Abstract][Full Text] [Related]
8. Vaccine safety surveillance informs public health policy beyond immunization: A case-series on bleeding following vaccination, Nepal, 2016-2018.
Pradhan R; Sharma Gautam J; Tinkari BS; Adhikari N; Bose AS
Vaccine; 2020 Sep; 38(40):6320-6326. PubMed ID: 32788134
[TBL] [Abstract][Full Text] [Related]
9. Surveillance for adverse events following immunization from 2008 to 2011 in Zhejiang Province, China.
Hu Y; Li Q; Lin L; Chen E; Chen Y; Qi X
Clin Vaccine Immunol; 2013 Feb; 20(2):211-7. PubMed ID: 23239804
[TBL] [Abstract][Full Text] [Related]
10. [Analysis on death from adverse event following immunization surveillance system of Shandong Province during 2011-2016].
Zhang YJ
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Aug; 51(8):723-727. PubMed ID: 28763922
[No Abstract] [Full Text] [Related]
11. Vaccine Safety and Surveillance for Adverse Events Following Immunization (AEFI) in India.
Joshi J; Das MK; Polpakara D; Aneja S; Agarwal M; Arora NK
Indian J Pediatr; 2018 Feb; 85(2):139-148. PubMed ID: 29170922
[TBL] [Abstract][Full Text] [Related]
12. [Surveillance of adverse events following immunization in Minhang district of Shanghai from 2007 to 2010].
Zhang LP; Yu F; Jin BF; Wang Y; Xu HL; DU Y
Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):859-64. PubMed ID: 23302620
[TBL] [Abstract][Full Text] [Related]
13. Surveillance of adverse events following immunization of 13-valent pneumococcal conjugate vaccine among infants, in Zhejiang province, China.
Hu Y; Pan X; Chen F; Wang Y; Liang H; Shen L; Chen Y; Lv H
Hum Vaccin Immunother; 2022 Dec; 18(1):2035141. PubMed ID: 35240930
[TBL] [Abstract][Full Text] [Related]
14. Causality assessment of serious and severe adverse events following immunization in India: a 4-year practical experience.
Singh AK; Wagner AL; Joshi J; Carlson BF; Aneja S; Boulton ML
Expert Rev Vaccines; 2018 Jun; 17(6):555-562. PubMed ID: 29865876
[TBL] [Abstract][Full Text] [Related]
15. Real-world safety profile of the 9-valent human papillomavirus vaccine: A study in Zhejiang, China from 2019 to 2021.
Chen F; Pan X; Liang H; Shen L; Wang Y; Chen Y; Lv H; Hu Y
Hum Vaccin Immunother; 2022 Dec; 18(7):2152256. PubMed ID: 36484114
[TBL] [Abstract][Full Text] [Related]
16. Change in adverse event reporting following immunization of hepatitis B vaccine among infants between 2013 to 2020 before and after the vaccine administration law in China.
Wang C; Huang N; Lu QB; Black S; Liang X; Cui F
Front Immunol; 2022; 13():956473. PubMed ID: 36248783
[TBL] [Abstract][Full Text] [Related]
17. Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign.
Gbenewei E; Nomhwange T; Taiwo L; Ayodeji I; Yusuf K; Jean Baptiste AE; Nsubuga P; Braka F; Oteri J; Shuaib F
Vaccine; 2021 Nov; 39 Suppl 3():C82-C88. PubMed ID: 33714655
[TBL] [Abstract][Full Text] [Related]
18. Adverse events following immunisation (AEFI) reports from the Zimbabwe expanded programme on immunisation (ZEPI): an analysis of spontaneous reports in Vigibase® from 1997 to 2017.
Masuka JT; Khoza S
BMC Public Health; 2019 Aug; 19(1):1166. PubMed ID: 31455314
[TBL] [Abstract][Full Text] [Related]
19. Canadian vaccine safety surveillance reports following immunization with seasonal influenza vaccines, 2021-2022.
Giang E; Xu Y; Naganathan T; Abraham N; Bawolak MT; Salim BS; Weeks A; Shaw A; Ogunnaike-Cooke S
Can Commun Dis Rep; 2024 Jan; 50(1-2):16-24. PubMed ID: 38655243
[TBL] [Abstract][Full Text] [Related]
20. Analysis of deaths following yeast-derived hepatitis B vaccination of infants, China, January 2013 to December 2020.
Zhang S; Zhao T; Chen L; Xie M; Lu QB; Du J; Zeng J; Huang N; Liu Y; Wang C; Cui F
Front Public Health; 2023; 11():1170483. PubMed ID: 37397780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
